Literature DB >> 9718056

Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population.

Q He1, M K Viljanen, H Arvilommi, B Aittanen, J Mertsola.   

Abstract

CONTEXT: The prevalence of Bordetella pertussis and Bordetella parapertussis infections among outpatients in an immunized population is not known.
OBJECTIVE: To study the prevalence of these infections in outpatients with paroxysmal cough in Finland, where the pertussis vaccine coverage of 4 doses is 98%.
DESIGN: Prospective cohort study.
SETTING: Thirty-two health centers in southwestern Finland. PATIENTS: A total of 584 patients with paroxysmal cough seen at local health centers from October 1994 through March 1997 from whom nasopharyngeal swabs were collected. MAIN OUTCOME MEASURES: Prevalence of positive cultures for B pertussis or B parapertussis and/or positive polymerase chain reaction (PCR) results and frequency of symptoms in those with pertussis and parapertussis.
RESULTS: A total of 153 subjects (26.2%) had Bordetella infection by culture or PCR: 93 (60.8%) had B pertussis infection, 49 (32.0%) had B parapertussis infection, and 1 1 (7.2%) had both. Of these cases, 39 (25.5%) had positive cultures and 95 (62.1%) had positive PCR results for B pertussis, and 19 (12.4%) had positive cultures and 55 (35.9%) had positive PCR results for B parapertussis. At the time of diagnosis, no difference was found in the frequency of symptoms between patients with B parapertussis infection and those with B pertussis infection. Bordetella parapertussis infection was as common as B pertussis infection in children before school entry, whereas in schoolchildren and adults, B pertussis infection was more common than B parapertussis infection (P<.001).
CONCLUSION: Bordetella infections are common in an immunized population, and B parapertussis infections apparently are more prevalent than previously documented.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718056     DOI: 10.1001/jama.280.7.635

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  41 in total

1.  Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.

Authors:  C M Ausiello; R Lande; F Urbani; A la Sala; P Stefanelli; S Salmaso; P Mastrantonio; A Cassone
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 2.  Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens.

Authors:  R Moxon; C Tang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

3.  Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.

Authors:  C Fayolle; A Osickova; R Osicka; T Henry; M J Rojas; M F Saron; P Sebo; C Leclerc
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.

Authors:  Natacha Kourova; Valérie Caro; Christian Weber; Sabine Thiberge; Raisa Chuprinina; Galina Tseneva; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

5.  Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland.

Authors:  I Letowska; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-27       Impact factor: 3.267

6.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

8.  Patterns of susceptibility in an outbreak of Bordetella pertussis: evidence from a community-based study.

Authors:  David M Moore; Richard G Mathias
Journal:  Can J Infect Dis       Date:  2002-09

Review 9.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.